Oncologists seldom respond with empathy when their ptients express emotional concerns.
Oncologists seldom respond with empathy when their ptients express emotional concerns, according to research published in the Dec. 20 issue of the Journal of Clinical Oncology. This could cause physicians to miss opportunities to strengthen the doctor-patient relationship and improve patient adherence.
Kathryn I. Pollak, PhD, of the Duke University Medical Center in Durham, NC, and colleagues analyzed 398 conversations between 51 oncologists and their patients, noting the opportunities that patients presented for empathy and the physicians' responses. Physicians could respond with "continuers" that allowed patients to express more emotions, or "terminators" that discouraged additional disclosure.
Thirty-seven percent of the conversations contained at least one opportunity for empathy, but oncologists only responded with continuers 22% of the time. Younger physicians and those who rated themselves as more socioemotional than technical in orientation were more likely to respond with empathy.
Pollak KI, Arnold RM, Jeffreys AS, et al. Oncologist communication about emotion during visits with patients with advanced cancer. J Clin Oncol. 2007;25:5748-5752.
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More